Discover
FBIO
Fortress Biotech, Inc.
2.61
19 x 2.55
2 x 2.63
bid
ask
-
0.14
5.09%
4970 @ 04:00 PM
2.58 -0.03 (1.09%)
| Ytd | -28.69% | |
| 1y | 35.94% |
2.60
day range
2.74
1.90
52 week range
4.53
| Open | 2.74 | Prev Close | 2.75 | Low | 2.60 | High | 2.74 | Mkt Cap | 86.70M |
| Vol | 0.00 | Avg Vol | 571.55K | EPS | 2.26 | P/E | 1.15 | Forward P/E | -0.99 |
| Beta | 1.75 | Short Ratio | 4.57 | Inst. Own | 15.78% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 3.05 | 200-d Avg | 2.98 | 1yr Est | 14.33 |
| Income Statement | |||
| Total Revenue | 16.04M | ||
| Revenues (USD) | 16.04M | ||
| Cost of Revenue | 6.22M | ||
| Gross Profit | 9.82M | ||
| Operating Expenses | 17.56M | ||
| Research and Development Expense | 540.00K | ||
| Selling, General and Administrative Expense | 15.89M | ||
| Operating Income | -7.74M | ||
| Interest Expense | 3.37M | ||
| Income Tax Expense | 5.13M | ||
| Net Income | 110.37M | ||
| Net Income Common Stock | 108.37M | ||
| Net Income Common Stock (USD) | 108.37M | ||
| Consolidated Income | 137.16M | ||
| Net Income to Non-Controlling Interests | 26.79M | ||
| Earnings per Basic Share | 3.44 | ||
| Earnings per Basic Share (USD) | 3.44 | ||
| Earnings per Diluted Share | 2.82 | ||
| Earning Before Interest & Taxes (EBIT) | 118.87M | ||
| Earning Before Interest & Taxes (USD) | 118.87M | ||
| Preferred Dividends Income Statement Impact | 2.01M | ||
| Weighted Average Shares | 31.54M | ||
| Weighted Average Shares Diluted | 38.41M | ||
| Balance Sheet | |||
| Cash and Equivalents | 257.06M | ||
| Cash and Equivalents (USD) | 257.06M | ||
| Investments | 18.71M | ||
| Investments Non-Current | 18.71M | ||
| Trade and Non-Trade Receivables | 25.51M | ||
| Current Assets | 295.48M | ||
| Property, Plant & Equipment Net | 14.25M | ||
| Total Assets | 356.87M | ||
| Debt Current | 4.72M | ||
| Total Debt | 53.63M | ||
| Current Liabilities | 103.39M | ||
| Debt Non-Current | 48.91M | ||
| Total Liabilities | 154.50M | ||
| Accumulated Retained Earnings (Deficit) | -623.68M | ||
| Shareholders Equity | 162.21M | ||
| Shareholders Equity (USD) | 162.21M | ||
| Assets Non-Current | 61.39M | ||
| Total Debt (USD) | 53.63M | ||
| Goodwill and Intangible Assets | 26.48M | ||
| Inventory | 9.29M | ||
| Liabilities Non-Current | 51.11M | ||
| Trade and Non-Trade Payables | 92.99M | ||
| Tax Liabilities | 5.42M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.70M | ||
| Net Cash Flow from Financing | -27.39M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 176.46M | ||
| Issuance (Repayment) of Debt Securities | -14.49M | ||
| Net Cash Flow from Operations | 203.85M | ||
| Share Based Compensation | 1.76M | ||